tolbutamide has been researched along with 8-bromocyclic gmp in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellman, B; Wesslén, N | 1 |
| Mohan, RM; Paterson, DJ | 1 |
| Almond, SC; Paterson, DJ | 1 |
| Ishikawa, T; Kaneko, Y; Nakayama, K; Sugino, F | 1 |
4 other study(ies) available for tolbutamide and 8-bromocyclic gmp
| Article | Year |
|---|---|
Characterization of the glucose-induced lowering of sodium in mouse pancreatic beta-cells.
Topics: 3-O-Methylglucose; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Bumetanide; Cyclic GMP; Glucose; Islets of Langerhans; Methylglucosides; Mice; Mice, Obese; Ouabain; Potassium Channels; Quinine; Sodium; Sodium Channels; Tolbutamide | 1988 |
Activation of sulphonylurea-sensitive channels and the NO-cGMP pathway decreases the heart rate response to sympathetic nerve stimulation.
Topics: Analysis of Variance; Animals; Cyclic GMP; Diazoxide; Electric Stimulation; Enzyme Inhibitors; Glyburide; Guinea Pigs; Heart Atria; Heart Rate; Hypoxia; In Vitro Techniques; Male; Nitric Oxide; Norepinephrine; Potassium Channel Blockers; Potassium Channels; Stellate Ganglion; Sympathetic Nervous System; Tolbutamide | 2000 |
Sulphonylurea-sensitive channels and NO-cGMP pathway modulate the heart rate response to vagal nerve stimulation in vitro.
Topics: Acetylcholine; Animals; Cyclic GMP; Diazoxide; Electric Stimulation; Glyburide; Guinea Pigs; Heart Conduction System; Heart Rate; Ion Transport; Male; Muscle Proteins; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Potassium; Potassium Channels; Signal Transduction; Sulfonylurea Compounds; Tolbutamide; Vagus Nerve | 2000 |
Two distinct effects of cGMP on cytosolic Ca2+ concentration of rat pancreatic beta-cells.
Topics: 4-Aminopyridine; Animals; Calcium; Cyclic GMP; Cytosol; Dimethyl Sulfoxide; Enzyme Inhibitors; Glucose; Hydrazines; Hypoglycemic Agents; Islets of Langerhans; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Potassium; Potassium Channel Blockers; Quinoxalines; Rats; Tolbutamide | 2003 |